Memorial Sloan Kettering Cancer Center, Department of Surgery, Urology Service, USA; VA New York Harbor Healthcare System, USA.
VA New York Harbor Healthcare System, USA; New York University, Grossman School of Medicine, Department of Urology, USA.
Cancer Epidemiol. 2022 Jun;78:102088. doi: 10.1016/j.canep.2021.102088. Epub 2021 Dec 18.
Cancer survivors benefit from evidence-based smoking cessation treatment. A crucial first step in this process is a clinician recommending that the patient quit smoking. However, contemporary delivery of advice to quit among patients with cancer is not well known. In a cross-sectional analysis of all adult smokers included in a prospective population-representative study of US adults, we analyzed the frequency that patients reported receiving advice to quit smoking from a healthcare professional according to reported cancer history (no cancer, tobacco-related cancer, non-tobacco related cancer history). Among an estimated 28.3 million smokers, 9.3% reported a history of cancer, 48.8% of which were tobacco-related cancers. In general, advice to quit was reported by more (67.8%) cancer survivors than those adults without any cancer (56.0%). After adjustment for sociodemographic factors, smokers with a non tobacco-related cancer (0.51, 95% CI 0.32-0.83) and those without any cancer history (0.43, 95% CI 0.30-0.63) were both less likely to report being advised to quit smoking than patients with a tobacco-related cancer history.
癌症幸存者从基于证据的戒烟治疗中受益。这个过程的关键第一步是临床医生建议患者戒烟。然而，目前癌症患者戒烟建议的提供情况并不为人所知。我们对一项前瞻性美国成年人代表性研究中所有成年吸烟者进行了横断面分析，根据报告的癌症史（无癌症、与烟草相关的癌症、非烟草相关癌症史）分析了患者报告从医疗保健专业人员那里获得戒烟建议的频率。在估计的 2830 万吸烟者中，9.3%报告有癌症史，其中 48.8%为与烟草相关的癌症。一般来说，与没有任何癌症的成年人（56.0%）相比，更多的癌症幸存者（67.8%）报告接受了戒烟建议。在调整了社会人口因素后，与有与烟草相关的癌症史的患者相比，无任何癌症史（0.43，95%CI 0.30-0.63）和非烟草相关癌症史的患者（0.51，95%CI 0.32-0.83）报告接受戒烟建议的可能性均较小。
